Literature DB >> 24521246

Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation.

Qi Yang1, Stephen W Jones, Christina L Parker, William C Zamboni, James E Bear, Samuel K Lai.   

Abstract

Coating nanoparticles with polyethylene glycol (PEG), which reduces particle uptake and clearance by immune cells, is routinely used to extend the circulation times of nanoparticle therapeutics. Nevertheless, due to technical hurdles in quantifying the extent of PEG grafting, as well as in generating very dense PEG coatings, few studies have rigorously explored the precise PEG grafting density necessary to achieve desirable "stealth" properties. Here, using polymeric nanoparticles with precisely tunable PEG grafting, we found that, for a wide range of PEG lengths (0.6-20 kDa), PEG coatings at densities substantially exceeding those required for PEG to adopt a "brush" conformation are exceptionally resistant to uptake by cultured human macrophages, as well as primary peripheral blood leukocytes. Less than 20% of these nanoparticles were cleared from the blood after 2 h (t1/2 ∼ 14 h) in BALB/c mice, whereas slightly less densely PEGylated and uncoated control particles were both virtually eliminated within 2 h. Our results suggest that the stealth properties of PEG-coated nanoparticles are critically dependent on achieving PEG grafting at densities exceeding those required for brush conformation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24521246     DOI: 10.1021/mp400703d

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  61 in total

1.  Optimizing Quantum Dot Probe Size for Single-Receptor Imaging.

Authors:  Phuong Le; Rohit Vaidya; Lucas D Smith; Zhiyuan Han; Mohammad U Zahid; Jackson Winter; Suresh Sarkar; Hee Jung Chung; Pablo Perez-Pinera; Paul R Selvin; Andrew M Smith
Journal:  ACS Nano       Date:  2020-07-16       Impact factor: 15.881

Review 2.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

3.  PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils.

Authors:  William J Kelley; Catherine A Fromen; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Acta Biomater       Date:  2018-09-06       Impact factor: 8.947

4.  Minimizing biases associated with tracking analysis of submicron particles in heterogeneous biological fluids.

Authors:  Ying-Ying Wang; Kenetta L Nunn; Dimple Harit; Scott A McKinley; Samuel K Lai
Journal:  J Control Release       Date:  2015-10-18       Impact factor: 9.776

Review 5.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

6.  Macrophage silica nanoparticle response is phenotypically dependent.

Authors:  Heather L Herd; Kristopher T Bartlett; Joshua A Gustafson; Lawrence D McGill; Hamidreza Ghandehari
Journal:  Biomaterials       Date:  2015-03-23       Impact factor: 12.479

7.  Engineering Polymer-Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus-Covered Epithelium.

Authors:  Justin T Huckaby; Christina L Parker; Tim M Jacobs; Alison Schaefer; Daniel Wadsworth; Alexander Nguyen; Anting Wang; Jay Newby; Samuel K Lai
Journal:  Angew Chem Int Ed Engl       Date:  2019-03-21       Impact factor: 15.336

8.  Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.

Authors:  Karin L Lee; Sourabh Shukla; Mengzhi Wu; Nadia R Ayat; Caroline E El Sanadi; Amy M Wen; John F Edelbrock; Jonathan K Pokorski; Ulrich Commandeur; George R Dubyak; Nicole F Steinmetz
Journal:  Acta Biomater       Date:  2015-03-10       Impact factor: 8.947

9.  Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery.

Authors:  Jasmim Leal; Xiujuan Peng; Xinquan Liu; Dhivya Arasappan; Dennis C Wylie; Sarah H Schwartz; Jason J Fullmer; Bennie C McWilliams; Hugh D C Smyth; Debadyuti Ghosh
Journal:  J Control Release       Date:  2020-03-31       Impact factor: 9.776

10.  Biomimetic nanovesicle design for cardiac tissue repair.

Authors:  Sruti Bheri; Jessica R Hoffman; Hyun-Ji Park; Michael E Davis
Journal:  Nanomedicine (Lond)       Date:  2020-08-05       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.